Lisata Therapeutics LSTA
NASDAQ LSTA
$1.47 -0.02 (-1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lisata Therapeutics (LSTA) Selling, General & Administrative (2010 - 2026)

Updated

Lisata Therapeutics' Selling, General & Administrative came in at $3.41 million for Q2 2026, up 26.9% from $2.69 million a year earlier but down 8.8% from the prior quarter.

Analysis

Lisata Therapeutics (LSTA) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Lisata Therapeutics reported Selling, General & Administrative of $11.65 million, down 0.7% year-over-year; for FY2025, it came in at $10.43 million, down 13.6% from FY2024.

  • Selling, General & Administrative has declined in each of the last three years, though with a five-year compound annual growth rate of 1.1% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $12.08 million in FY2024 (-6.9%), $12.97 million in FY2023 (-8.3%), $14.14 million in FY2022 (+23.2%) and $11.47 million in FY2021 (+16.0%).
  • The five-year range for quarterly Selling, General & Administrative is $2.05 million (Q4 2025) to $3.99 million (Q3 2022).
  • Year-over-year, Selling, General & Administrative increased in three of the last eight quarters, with an average decline of 0.7%.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2022 (growth of 40.4%), and the weakest in Q3 2023 (a decline of 35.3%).
  • Business Quant data shows LSTA's Selling, General & Administrative at $3.74 million (Q1 2026), $2.05 million (Q4 2025) and $2.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Lisata Therapeutics 13.59 Mn 13.33 Mn - 3.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.41 Mn
Mar 31, 2026 3.74 Mn
Dec 31, 2025 2.05 Mn
Sep 30, 2025 2.46 Mn
Jun 30, 2025 2.69 Mn
Mar 31, 2025 3.25 Mn
Dec 31, 2024 3.00 Mn
Sep 30, 2024 2.79 Mn
Jun 30, 2024 2.92 Mn
Mar 31, 2024 3.36 Mn
Dec 31, 2023 3.01 Mn
Sep 30, 2023 2.58 Mn
Jun 30, 2023 3.71 Mn
Mar 31, 2023 3.67 Mn
Dec 31, 2022 3.33 Mn
Sep 30, 2022 3.99 Mn
Jun 30, 2022 3.49 Mn
Mar 31, 2022 3.34 Mn
Dec 31, 2021 2.80 Mn
Sep 30, 2021 2.84 Mn
API Access

Lisata Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LSTA&period=max&api_key=YOUR_API_KEY